A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells

por Seo,Hyang‑Hee, Kim,Sang Woo, Lee,Chang Youn, Lim,Kyu Hee, Lee,Jiyun, Choi,Eunhyun, Lim,Soyeon, Lee,Seahyoung, Hwang,Ki‑Chul
Publicado 2017

Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma

por Osman Cen, Karuppiah Kannan, Jessica Huck Sappal, Jie Yu, Mengkun Zhang, Muzaffer Arikan, Ali Ucur, Duran Ustek, Yeter Cen, Leo Gordon, Richard Longnecker
Publicado 2018

Signaling through Syk or CARD9 Mediates Species-Specific Anti-<italic toggle="yes">Candida</italic> Protection in Bone Marrow Chimeric Mice

por Erik Zajta, Katalin Csonka, Adél Tóth, Laszló Tiszlavicz, Tamás Németh, Anita Orosz, Ádám Novák, Máté Csikós, Csaba Vágvölgyi, Attila Mócsai, Attila Gácser
Publicado 2021

SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic SteatohepatitisSummary

por Carmelo Luci, Elodie Vieira, Manon Bourinet, Déborah Rousseau, Stéphanie Bonnafous, Stéphanie Patouraux, Lauren Lefevre, Frederic Larbret, Virginie Prod’homme, Antonio Iannelli, Albert Tran, Rodolphe Anty, Béatrice Bailly-Maitre, Marcel Deckert, Philippe Gual
Publicado 2022

Multiple Components Rapidly Screened from Perilla Leaves Attenuate Asthma Airway Inflammation by Synergistic Targeting on Syk

por Yang H, Sun W, Ma P, Yao C, Fan Y, Li S, Yuan J, Zhang Z, Li X, Lin M, Hou Q
Publicado 2020

Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma&ndash;COPD Overlap in vivo and in vitro

por Li S, Hui Y, Yuan J, Zhang Z, Li X, Fang N, Lin M, Hou Q
Publicado 2021